{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T15:59:07Z","timestamp":1788623947028,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Corneal Society"},{"name":"the Charitable Trust Fund for Ophthalmic Research in the Commemoration of Santen Pharmaceutical\u2019s Founder"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-77160-9","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T04:43:52Z","timestamp":1730090632000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Inhibiting corneal transplantation rejection via lymphatic vessel ligation in a novel murine model"],"prefix":"10.1038","volume":"14","author":[{"given":"Ami","family":"Igarashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiko","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Yuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Yamagami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,28]]},"reference":[{"key":"77160_CR1","doi-asserted-by":"publisher","first-page":"e1434","DOI":"10.1097\/TXD.0000000000001434","volume":"9","author":"Y Zhou","year":"2023","unstructured":"Zhou, Y., Wang, T., Tuli, S. S., Steigleman, W. A. & Shah, A. A. Overview of corneal transplantation for the nonophthalmologist. Transpl. Direct. 9, e1434 (2023).","journal-title":"Transpl. Direct"},{"key":"77160_CR2","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1080\/02713683.2020.1737716","volume":"45","author":"MT Pluzsik","year":"2020","unstructured":"Pluzsik, M. T. et al. Changing trends in penetrating keratoplasty indications between 2011 and 2018 - histopathology of 2123 corneal buttons in a single Center in Germany. Curr. Eye Res. 45, 1199\u20131204 (2020).","journal-title":"Curr. Eye Res."},{"key":"77160_CR3","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/j.1442-9071.2005.01107.x","volume":"33","author":"VS Sangwan","year":"2005","unstructured":"Sangwan, V. S., Ramamurthy, B., Shah, U., Garg, P. & Sridhar, M. S. Rao, G. N. Outcome of corneal transplant rejection: A 10-year study. Clin. Exp. Ophthalmol. 33, 623\u2013627 (2005).","journal-title":"Clin. Exp. Ophthalmol."},{"key":"77160_CR4","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/j.1600-0420.1996.tb00740.x","volume":"74","author":"S Yamagami","year":"1996","unstructured":"Yamagami, S., Suzuki, S. & Tsuru, T. Risk factors for graft failure in penetrating keratoplasty. Acta Ophthalmol. Scand. 74, 584\u2013588 (1996).","journal-title":"Acta Ophthalmol. Scand."},{"key":"77160_CR5","first-page":"1293","volume":"42","author":"S Yamagami","year":"2001","unstructured":"Yamagami, S. & Dana, M. R. The critical role of draining lymph nodes in corneal alloimmunization and graft rejection. Invest. Ophthalmol. Vis. Sci. 42, 1293\u20131298 (2001).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"77160_CR6","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.3390\/cells10071661","volume":"10","author":"Y Hou","year":"2021","unstructured":"Hou, Y., Bock, F., Hos, D. & Cursiefen, C. Lymphatic trafficking in the eye: Modulation of lymphatic trafficking to promote corneal transplant survival. Cells. 10, 1661 (2021).","journal-title":"Cells"},{"key":"77160_CR7","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1167\/iovs.03-1380","volume":"5","author":"C Cursiefen","year":"2004","unstructured":"Cursiefen, C. et al. Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival. Invest. Ophthalmol. Vis. Sci. 5, 2666\u20132673 (2004).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"77160_CR8","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00441-016-2493-8","volume":"366","author":"M Lohrberg","year":"2016","unstructured":"Lohrberg, M. & Wilting, J. The lymphatic vascular system of the mouse head. Cell. Tissue Res. 366, 667\u2013677 (2016).","journal-title":"Cell. Tissue Res."},{"key":"77160_CR9","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1080\/01616412.2018.1446282","volume":"40","author":"M Maloveska","year":"2018","unstructured":"Maloveska, M. et al. Dynamics of Evans blue clearance from cerebrospinal fluid into meningeal lymphatic vessels and deep cervical lymph nodes. Neurol. Res. 40, 372\u2013380 (2018).","journal-title":"Neurol. Res."},{"key":"77160_CR10","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1136\/bjo.86.1.108","volume":"86","author":"J Plskov\u00e1","year":"2002","unstructured":"Plskov\u00e1, J., Kuffov\u00e1, L., Hol\u00e1n, V., Filipec, M. & Forrester, J. V. Evaluation of corneal graft rejection in a mouse model. Br. J. Ophthalmol. 86, 108\u2013113 (2002).","journal-title":"Br. J. Ophthalmol."},{"key":"77160_CR11","first-page":"3341","volume":"41","author":"S Hegde","year":"2000","unstructured":"Hegde, S. & Niederkorn, J. Y. The role of cytotoxic T lymphocytes in corneal allograft rejection. Invest. Ophthalmol. Vis. Sci. 41, 3341\u20133347 (2000).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"77160_CR12","doi-asserted-by":"publisher","first-page":"e135121","DOI":"10.1172\/jci.insight.135121","volume":"5","author":"Y Wu","year":"2020","unstructured":"Wu, Y. et al. Organogenesis and distribution of the ocular lymphatic vessels in the anterior eye. JCI Insight. 5, e135121 (2020).","journal-title":"JCI Insight"},{"key":"77160_CR13","doi-asserted-by":"publisher","first-page":"16040","DOI":"10.1038\/s41598-020-71877-z","volume":"10","author":"M Subileau","year":"2020","unstructured":"Subileau, M. et al. Eye lymphatic defects induced by bone morphogenetic protein 9 deficiency have no functional consequences on intraocular pressure. Sci. Rep. 10, 16040 (2020).","journal-title":"Sci. Rep."},{"key":"77160_CR14","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1152\/physrev.00039.2021","volume":"102","author":"LC Dieterich","year":"2022","unstructured":"Dieterich, L. C., Tacconi, C., Ducoli, L. & Detmar, M. Lymphatic vessels in cancer. Physiol. Rev. 102, 1837\u20131879 (2022).","journal-title":"Physiol. Rev."},{"key":"77160_CR15","doi-asserted-by":"publisher","first-page":"eaax4063","DOI":"10.1126\/science.aax4063","volume":"369","author":"TV Petrova","year":"2020","unstructured":"Petrova, T. V. & Koh, G. Y. Biological functions of lymphatic vessels. Science. 369, eaax4063 (2020).","journal-title":"Science"},{"key":"77160_CR16","first-page":"2127","volume":"43","author":"C Cursiefen","year":"2002","unstructured":"Cursiefen, C. et al. Lymphatic vessels in vascularized human corneas:Iimmunohistochemical investigation using LYVE-1 and podoplanin. Invest. Ophthalmol. Vis. Sci. 43, 2127\u20132135 (2002).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"77160_CR17","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/nature05249","volume":"443","author":"BK Ambati","year":"2006","unstructured":"Ambati, B. K. et al. Corneal avascularity is due to soluble VEGF receptor-1. Nature. 443, 993\u2013997 (2006).","journal-title":"Nature"},{"key":"77160_CR18","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1172\/JCI20465","volume":"113","author":"C Cursiefen","year":"2004","unstructured":"Cursiefen, C. et al. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J. Clin. Invest. 113, 1040\u20131050 (2004).","journal-title":"J. Clin. Invest."},{"key":"77160_CR19","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.phrs.2015.11.027","volume":"103","author":"M Amadio","year":"2016","unstructured":"Amadio, M., Govoni, S. & Pascale, A. Targeting VEGF in eye neovascularization: What\u2019s new? A comprehensive review on current therapies and oligonucleotide-based interventions under development. Pharmacol. Res. 103, 253\u2013269 (2016).","journal-title":"Pharmacol. Res."},{"key":"77160_CR20","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/nm.2018","volume":"15","author":"RJC Albuquerque","year":"2009","unstructured":"Albuquerque, R. J. C. et al. Alternatively spliced VEGF receptor-2 is an essential endogenous inhibitor of lymphatic vessels. Nat. Med. 15, 1023\u20131030 (2009).","journal-title":"Nat. Med."},{"key":"77160_CR21","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1167\/tvst.11.5.6","volume":"11","author":"W Zhang","year":"2022","unstructured":"Zhang, W., Sch\u00f6nberg, A., Bock, F., Cursiefen, C. & Posttransplant VEGFR1R2 trap eye drops inhibit corneal (lymph)angiogenesis and improve corneal allograft survival in eyes at high risk of rejection. Transl Vis. Sci. Technol. 11, 6 (2022).","journal-title":"Transl Vis. Sci. Technol."},{"key":"77160_CR22","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1097\/TP.0000000000000512","volume":"99","author":"TH Dohlman","year":"2015","unstructured":"Dohlman, T. H. et al. VEGF-trap Aflibercept significantly improves long-term graft survival in high-risk corneal transplantation. Transplantation. 99, 678\u2013686 (2015).","journal-title":"Transplantation"},{"key":"77160_CR23","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/nm1078","volume":"10","author":"L Chen","year":"2004","unstructured":"Chen, L. et al. Vascular endothelial growth factor receptor-3 mediates induction of corneal alloimmunity. Nat. Med. 10, 813\u2013815 (2004).","journal-title":"Nat. Med."},{"key":"77160_CR24","first-page":"578","volume":"6","author":"GL Chen","year":"2013","unstructured":"Chen, G. L. et al. Evaluation of corneal graft survival in mice model. Int. J. Ophthalmol. 6, 578\u2013583 (2013).","journal-title":"Int. J. Ophthalmol."},{"key":"77160_CR25","first-page":"1835","volume":"10","author":"D Ma","year":"1998","unstructured":"Ma, D. et al. Conditions affecting enhanced corneal allograft survival by oral immunization. Invest. Ophthalmol. Vis. Sci. 10, 1835\u20131846 (1998).","journal-title":"Invest. Ophthalmol. Vis. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77160-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77160-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77160-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T05:05:47Z","timestamp":1730351147000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77160-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,28]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["77160"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-77160-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4439625\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,28]]},"assertion":[{"value":"18 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25692"}}